October 2019 - Clinical trial profile - geography, conditions, sponsors -

Clinical Trials for Voltaren

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00171691	Safety of Diclofenac Sodium Gel in Knee Osteoarthritis	Completed	Novartis	Phase 3	2004-10-01	This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis.
NCT00276419	Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin	Terminated	Mayo Clinic	Phase 2/Phase 3	2005-06-01	The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.
NCT00310908	Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic	Completed	Grumental	Phase 4	2006-09-01	The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
NCT00310908	Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic	Completed	Hadassah Medical Organization	Phase 4	2006-09-01	The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
NCT00523120	Topical Voltaren in Otitis Externa	Terminated	Sieff Medical Center	Phase 2	2008-09-01	Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.
NCT00715091	Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis	Completed	Charite University, Berlin, Germany	Phase 4	2008-09-01	This is a randomised, controlled, multi-centre clinical trial on AS patients. Experimental intervention: continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren Resinate), divided into 75mg Voltaren twice dailyControl intervention: treatment on-demand (as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment strategy of the control intervention (on-demand) reflects current clinical practice in AS. Duration of intervention per patient: 2 years Follow-up per patient: safety assessment 3 months after termination of the trial.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary